Pillstats
Rx only · Tablet · Oral

Glyburide

Glyburide

16 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US57 NDCs
16 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)
US makers16 labelers
Packages160
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 30 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.022$0.045$0.067$0.090Dec 2025Mar 2026Jun 2026
$0.075
Latest avg · Jun 17, 2026
-4%
Since Dec 17, 2025
16
Active US suppliers
24%
Top-2 supplier share*

Who makes it16 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Teva Pharmaceuticals USA, Inc.unknown20SUPPLYING
Zydus Lifesciences Limitedunknown18SUPPLYING
Zydus Pharmaceuticals USA Inc.unknown18SUPPLYING
A-S Medication Solutionsunknown16SUPPLYING
Bryant Ranch Prepackrepackager15SUPPLYING
NuCare Pharmaceuticals, Inc.unknown14SUPPLYING
Proficient Rx LPunknown11SUPPLYING
Modavar Pharmaceuticals LLCunknown8SUPPLYING
Preferred Pharmaceuticals Inc.unknown8SUPPLYING
Cadila Pharmaceuticals Limitedunknown8SUPPLYING
Nivagen Pharmaceuticals, Inc.unknown6SUPPLYING
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.unknown6SUPPLYING
Northwind Health Company, LLCunknown4SUPPLYING
REMEDYREPACK INC.repackager4SUPPLYING
Chartwell RX, LLCunknown3SUPPLYING

+ 1 more labelers

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.